Cargando…
The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer
Estrogen receptor positive breast neoplasias represent over 70% of diagnosed breast cancers. Depending on the stage at which the tumor is detected, HER2 status and genomic risk, endocrine therapy is combined with either radio, chemo and/or targeted therapy. A growing amount of evidence supports the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694443/ https://www.ncbi.nlm.nih.gov/pubmed/31440208 http://dx.doi.org/10.3389/fendo.2019.00547 |